Herpes simplex prophylactic vaccine - XenovaAlternative Names: DISC-PRO
Latest Information Update: 13 Sep 2010
At a glance
- Originator Xenova Group
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Herpes simplex virus infections